Welcome to ACLAIRO
Aclairo’s full time staff offers decades of experience as industry scientists and strategists; FDA supervisors and reviewers; and operations specialists to integrate and solve the complexities in pharmaceutical, device, and gene therapy development. We implement our deep experience-based approach to provide strategic, scientific regulatory services, and operations support.
Aclairo welcomes our new president effective July, 2019 — Heath Thomas !!!